| Autor: |
Hossain MK; Laboratory of Pharmaceutical Technology, Pharmacy Discipline, Khulna University, Khulna-9208, Bangladesh. ; Opsonin Pharma Limited, 30, New Eskaton Road, Dhaka-1000, Bangladesh., Khatun A; Laboratory of Pharmaceutical Technology, Pharmacy Discipline, Khulna University, Khulna-9208, Bangladesh. ; Southern Cross University, Lismore, NSW- 2480, Australia., Rahman M; Laboratory of Pharmaceutical Technology, Pharmacy Discipline, Khulna University, Khulna-9208, Bangladesh. ; Southern Cross University, Lismore, NSW- 2480, Australia., Akter MN; Laboratory of Pharmaceutical Technology, Pharmacy Discipline, Khulna University, Khulna-9208, Bangladesh., Chowdhury SA; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Dhaka, Dhaka-1000, Bangladesh., Alam SM; Laboratory of Pharmaceutical Technology, Pharmacy Discipline, Khulna University, Khulna-9208, Bangladesh. ; Chancery, High Commission for the People's Republic of Bangladesh, London. |
| Abstrakt: |
Purpose: This project was aimed to determine the effect of concurrent administration of sulfamethoxazole and diclofenac sodium. Methods: Equilibrium dialysis method was adopted to study different protein binding aspects of sulfamethoxazole and diclofenac sodium. Results: Sulfamethoxazole showed two types of association constants; high affinity constant 29.0±0.20×10 6 M -1 with lower number of binding sites of 0.7±1 and low affinity constant 1.13±0.20×10 6 M -1 with higher number of binding sites of 3.45±1 at pH 7.4 and 40 °C temperature. Diclofenac sodium showed high affinity constant 33.66±0.20×10 6 M -1 with lower number of binding sites of 1.01±1 and low affinity constant 1.72±0.20×10 6 M -1 with higher number of binding sites of 6.40±1 at the same condition. Site specific probe displacement data implied that site-I, warfarin sodium site, was the high affinity site, while site-II, diazepam site, was the low affinity site for these drugs. During concurrent administration, sulfamethoxazole increased the free concentration of diclofenac sodium from 17.5±0.14% to 70.0±0.014% in absence and from 22.5±0.07% to 83.0±0.014% in presence of site-I specific probe. Diclofenac sodium also increased the free concentration of sulfamethoxazole from 2.8±0.07% to 52.0±0.14% and from 8.5±0.014% to 64.4±0.07% in absence and presence of site-I specific probe respectively. Conclusion: The study revealed that the concurrent administration of sulfamethoxazole and diclofenac sodium may result drug concentration alteration in blood. |
